Durham-based Priovant Therapeutics has announced positive results from its Phase 2 BEACON study evaluating brepocitinib in cutaneous sarcoidosis (CS). CS is an inflammatory granulomatous skin disease ...

Durham-based Precision BioSciences, a gene-editing company, has received regulatory clearance to begin a clinical study of its potential treatment for Duchenne muscular dystrophy (DMD), a rare ...

A trusted leader who offered a steady hand and strong leadership on an interim basis in an ever-changing research environment, Sharon Paynter, Ph.D., has been named Senior Vice Provost for Research ...

If 2025 had a theme for the Charlotte region's life sciences ecosystem, it was this: years of planning finally meeting their moment. From landmark facility openings to record-breaking workforce ...

Durham Tech Connects is a career networking event for professionals, students, and alumni from life sciences and related fields. This event is hosted by Durham Tech's Life Sciences Program.

A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body.

The GXP site feeds into a surge of biomanufacturing activity in the state’s Eastern Region. The region scored $7.1 billion of ...

The Greater Raleigh Chamber and Wake County Economic Development joined forces to host a dynamic event that explores the evolving life sciences landscape in Wake County and the Research Triangle ...

The annual NIEHS Biomedical Career Symposium, now in its 28th year, is one of the largest assemblies of biomedical organizations and early-career scientists in Research Triangle Park. Targeting ...